Grade 3–4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study
暂无分享,去创建一个
J. Trédaniel | G. Zalcman | A. Khalil | V. Gounant | N. Poté | S. Brosseau | C. Naltet | G. Soussi | B. Abbar | L. Hachon | Nadia Guezour | Charles Vauchier | Céline Namour | C. Vauchier | N. Guezour